Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a de... More · Chart
Full Profile of BCEL (Atreca Inc. Cl A) : Nasdaq
Market Cap: 362.1M | Industry: Health Care/Life Sciences
Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients...
Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients...